Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects

被引：0
|
作者：
Kim, Mi-Jung
Bae, Jung -Woo
Han, Ho-Kyun
Choi, Sun-Ok
Kim, Ok-Hee
Jang, Choon-Gon
Lee, Jin-Hee
Kim, Nam-Tae
Lee, Seok-Yong
机构：
[1] Sungkyunkwan Univ, Coll Pharm, Seoul, South Korea
[2] Natl Inst Toxicol Res, Seoul, South Korea
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
Irbesartan; CYP2C9; polymorphism; pharmacokinetics;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [11] Effects of CYP2C9 and CYP2C19 polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy Korean subjects.
    Choi, C.
    Bae, J.
    Kim, M.
    Jang, C.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S68 - S68
  • [12] CYP2C9 genetic polymorphisms significantly affected the pharmacokinetics of flurbiprofen in healthy Korean subjects
    Lim, Hye-Jin
    Kim, Dong-Hyun
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    PHARMACOTHERAPY, 2015, 35 (11): : E316 - E316
  • [13] Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects
    Hee-Doo Yoo
    Mi-Suk Kim
    Hea-Young Cho
    Yong-Bok Lee
    European Journal of Clinical Pharmacology, 2011, 67
  • [14] Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects
    Lee, Yun-Jeong
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    Choi, Chang-Ik
    Bae, Jung-Woo
    Sohn, Uy-Dong
    Jang, Choon-Gon
    Lee, Jeongmi
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (06) : 1232 - 1237
  • [15] Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects
    Yoo, Hee-Doo
    Kim, Mi-Suk
    Cho, Hea-Young
    Lee, Yong-Bok
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (09) : 889 - 898
  • [16] Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects
    Yun-Jeong Lee
    Ji-Yeong Byeon
    Young-Hoon Kim
    Se-Hyung Kim
    Chang-Ik Choi
    Jung-Woo Bae
    Uy-Dong Sohn
    Choon-Gon Jang
    Jeongmi Lee
    Seok-Yong Lee
    Archives of Pharmacal Research, 2015, 38 : 1232 - 1237
  • [17] Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
    Gardin, Anne
    Ufer, Mike
    Legangneux, Eric
    Rossato, Gianluca
    Jin, Yi
    Su, Zhenzhong
    Pal, Parasar
    Li, Wenkui
    Shakeri-Nejad, Kasra
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 349 - 361
  • [18] Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
    Anne Gardin
    Mike Ufer
    Eric Legangneux
    Gianluca Rossato
    Yi Jin
    Zhenzhong Su
    Parasar Pal
    Wenkui Li
    Kasra Shakeri-Nejad
    Clinical Pharmacokinetics, 2019, 58 : 349 - 361
  • [19] Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects
    Li, Z.
    Wang, G.
    Wang, L. -S.
    Zhang, W.
    Tan, Z. -R.
    Fan, L.
    Chen, B. -L.
    Li, Q.
    Liu, J.
    Tu, J. -H.
    Hu, D. -L.
    Liu, Z. -Q.
    Zhou, H. -H.
    XENOBIOTICA, 2009, 39 (10) : 788 - 793
  • [20] Effect of CYP2C9*3 allele on the pharmacokinetics of naproxen in Korean subjects
    Bae, Jung-Woo
    Kim, Ji-Hong
    Choi, Chang-Ik
    Kim, Mi-Jeong
    Kim, Hyung-Ji
    Byun, Seong-Ae
    Chang, Young-Soon
    Jang, Choon-Gon
    Park, Young-Seo
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (02) : 269 - 273
12345